Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma
Clinical trial NCT06424301 · RECRUITING
Trial details
- NCT number
- NCT06424301
- Sponsor
- Eye & ENT Hospital of Fudan University
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-20
- Primary completion
- 2025-09-30
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.